Tilray (NASDAQ:TLRY – Get Free Report) released its quarterly earnings results on Friday. The company reported ($0.10) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.03) by ($0.07), Zacks reports. Tilray had a negative return on equity of 2.00% and a negative net margin of 26.79%. The firm had revenue of $210.90 million for the quarter, compared to analyst estimates of $216.34 million. The firm’s quarterly revenue was up 8.7% on a year-over-year basis. Tilray updated its FY 2025 guidance to EPS.
Tilray Trading Down 10.2 %
NASDAQ TLRY opened at $1.23 on Friday. The stock has a 50 day moving average of $1.36 and a 200-day moving average of $1.62. Tilray has a 12 month low of $1.14 and a 12 month high of $2.97. The company has a market cap of $1.11 billion, a PE ratio of -4.56 and a beta of 2.08. The company has a current ratio of 2.47, a quick ratio of 1.57 and a debt-to-equity ratio of 0.08.
Insider Buying and Selling at Tilray
In other Tilray news, CFO Carl A. Merton purchased 26,000 shares of the business’s stock in a transaction on Friday, November 15th. The stock was acquired at an average price of $1.36 per share, with a total value of $35,360.00. Following the acquisition, the chief financial officer now directly owns 26,000 shares of the company’s stock, valued at $35,360. This trade represents a ∞ increase in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Insiders own 0.87% of the company’s stock.
Analyst Upgrades and Downgrades
View Our Latest Analysis on TLRY
About Tilray
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.
Further Reading
- Five stocks we like better than Tilray
- How to invest in marijuana stocks in 7 steps
- Bullish on Athleisure? Here’s Why Lululemon Stock Shines
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- MarketBeat Week in Review – 01/06 – 01/10
- Technology Stocks Explained: Here’s What to Know About Tech
- Driving Forward: Lucid’s Growing Sales and Gravity SUV’s Impact
Receive News & Ratings for Tilray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray and related companies with MarketBeat.com's FREE daily email newsletter.
